New triple therapy aims to boost leukemia remission
NCT ID NCT06451861
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a new drug combination (ABC-14) with two standard treatments for adults newly diagnosed with acute myeloid leukemia (AML). About 240 participants will receive either ABC-14, the traditional "3+7" chemotherapy, or a two-drug combo (AB-14). The goal is to see which approach leads to more complete remissions with fewer side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Guangdong Medical University
RECRUITINGZhanjiang, Guangdong, China
-
Dongguan General Hosptial
RECRUITINGDongguan, Guangdong, China
-
Foshan First People's Hospital
RECRUITINGFoshan, Guangdong, China
-
Guangdong Provincial People's Hospital
RECRUITINGGuangzhou, Guangdong, 510080, China
-
Hainan General Hosptial
RECRUITINGHaikou, Hainan, China
-
Shenzhen second people's Hospital
RECRUITINGShenzhen, Guangdong, China
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, China
-
The Fifth Affiliated Hospital of Guangzhou Medical University
RECRUITINGGuangzhou, Guangdong, China
-
The First Affiliated Hospital of Guangdong Pharmaceutical University
RECRUITINGGuangzhou, Guangdong, China
-
The First Affiliated Hospital of Guangzhou Medical University
RECRUITINGGuangzhou, Guangdong, China
-
The First Affiliated Hospital of Jinan University
RECRUITINGGuangzhou, Guangdong, China
-
The Second Affiliated Hospital of Guangzhou Medical University
RECRUITINGGuangzhou, Guangdong, China
-
Zhuhai General Hosptial
RECRUITINGZhuhai, Guangdong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill keep blood cancer at bay after a stem cell transplant?
- Could muscle loss predict blood cancer outcomes?
- Can a modified enzyme starve Hard-to-Treat blood cancers?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?